Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice
Authors
Keywords
-
Journal
Antioxidants
Volume 10, Issue 3, Pages 390
Publisher
MDPI AG
Online
2021-03-06
DOI
10.3390/antiox10030390
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High-Content Screening for the Detection of Drug-Induced Oxidative Stress in Liver Cells
- (2021) María Teresa Donato et al. Antioxidants
- Comprehensive analysis and insights gained from long-term experience of the Spanish DILI registry
- (2021) Camilla Stephens et al. JOURNAL OF HEPATOLOGY
- Variability of the Genes Involved in the Cellular Redox Status and Their Implication in Drug Hypersensitivity Reactions
- (2021) Pedro Ayuso et al. Antioxidants
- Understanding Idiosyncratic Toxicity: Lessons Learned from Drug-Induced Liver Injury
- (2020) Merrie Mosedale et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecular Biomarkers in Drug-Induced Liver Injury: Challenges and Future Perspectives
- (2020) Siyu Fu et al. Frontiers in Pharmacology
- HLA-B*14:01 and HLA-B*35:01 are associated with trimethoprim-sulfamethoxazole induced liver injury
- (2020) Yi-Ju Li et al. HEPATOLOGY
- Nevirapine Biotransformation Insights: An Integrated In Vitro Approach Unveils the Biocompetence and Glutathiolomic Profile of a Human Hepatocyte-Like Cell 3D Model
- (2020) Madalena Cipriano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inflammasome activation and regulation: toward a better understanding of complex mechanisms
- (2020) Danping Zheng et al. Cell Discovery
- Drug induced liver injury: an update
- (2020) Miren Garcia-Cortes et al. ARCHIVES OF TOXICOLOGY
- Polygenic architecture informs potential vulnerability to drug-induced liver injury
- (2020) Masaru Koido et al. NATURE MEDICINE
- Using advanced oxidation protein products and ischaemia-modified albumin to monitor oxidative stress levels in patients with drug-induced liver injury
- (2020) Lan-Lan Xiao et al. Scientific Reports
- Drug-induced liver injury in older people
- (2020) M Isabel Lucena et al. Lancet Gastroenterology & Hepatology
- Clinical Characteristics and Outcome of Drug‐Induced Liver Injury in the Older Patients: From the Young‐Old to the Oldest‐Old
- (2020) Rianne A. Weersink et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic Risk Factors in Drug‐Induced Liver Injury Due to Isoniazid‐Containing Antituberculosis Drug Regimens
- (2020) Paola Nicoletti et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Incidence and prevalence of acute hepatitis E virus infection in patients with suspected Drug‐Induced Liver Injury in the Spanish DILI Registry
- (2020) Judith Sanabria‐Cabrera et al. LIVER INTERNATIONAL
- Prevention and management of idiosyncratic drug-induced liver injury: Systematic review and meta-analysis of randomised clinical trials
- (2020) Hao Niu et al. PHARMACOLOGICAL RESEARCH
- Drug-induced injury due to flucloxacillin: relevance of multiple HLA alleles
- (2019) Paola Nicoletti et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury
- (2019) Elizabeth T. Cirulli et al. GASTROENTEROLOGY
- EASL Clinical Practice Guidelines: Drug-induced liver injury
- (2019) Raúl Andrade et al. JOURNAL OF HEPATOLOGY
- NAT2 variants and toxicity related to anti-tuberculosis agents: a systematic review and meta-analysis
- (2019) M. Richardson et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Genome-Wide Association Study Confirming the Association of NAT2 with Susceptibility to Anti-tuberculosis Drug–Induced Liver Injury in Thai Patients
- (2019) Supharat Suvichapanich et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Endoplasmic Reticulum Stress-induced Upregulation of STARD1 Promotes Acetaminophen-induced Acute Liver Failure
- (2019) Sandra Torres et al. GASTROENTEROLOGY
- Hepatocyte-Derived Exosomes Promote Liver Immune Tolerance: Possible Implications for Idiosyncratic Drug-Induced Liver Injury
- (2019) Natalie S Holman et al. TOXICOLOGICAL SCIENCES
- Rotenone Increases Isoniazid Toxicity but Does Not Cause Significant Liver Injury: Implications for the Hypothesis that Inhibition of the Mitochondrial Electron Transport Chain Is a Common Mechanism of Idiosyncratic Drug-Induced Liver Injury
- (2019) Tiffany Cho et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Drug-Induced Liver Injury — Types and Phenotypes
- (2019) Jay H. Hoofnagle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanistic Studies of Idiosyncratic DILI: Clinical Implications
- (2019) Jack Uetrecht Frontiers in Pharmacology
- Efficacy and safety of magnesium isoglycyrrhizinate injection in patients with acute drug‐induced liver injury: A phase II trial
- (2019) Yongfeng Wang et al. LIVER INTERNATIONAL
- Drug-induced liver injury
- (2019) Raul J. Andrade et al. Nature Reviews Disease Primers
- Alteration of mitochondrial DNA homeostasis in drug-induced liver injury
- (2019) Bernard Fromenty FOOD AND CHEMICAL TOXICOLOGY
- Diagnostic and prognostic assessment of suspected drug‐induced liver injury in clinical practice
- (2019) Raúl J. Andrade et al. LIVER INTERNATIONAL
- Genetic Predisposition to Drug-Induced Liver Injury
- (2019) Camilla Stephens et al. Clinics in Liver Disease
- Drug-Induced liver Injury Associated with Severe Cutaneous Hypersensitivity Reactions: A Complex Entity in Need of a Multidisciplinary Approach
- (2019) Judith Sanabria-Cabrera et al. CURRENT PHARMACEUTICAL DESIGN
- Immune Responses in the Liver
- (2018) Paul Kubes et al. Annual Review of Immunology
- Dynamic imaging of adaptive stress response pathway activation for prediction of drug induced liver injury
- (2018) Steven Wink et al. ARCHIVES OF TOXICOLOGY
- Heavy Consumption of Alcohol is Not Associated With Worse Outcomes in Patients With Idiosyncratic Drug-induced Liver Injury Compared to Non-Drinkers
- (2018) Lara Dakhoul et al. Clinical Gastroenterology and Hepatology
- Development and Validation of a Test to Identify Drugs That Cause Idiosyncratic Drug-Induced Liver Injury
- (2018) Andreas Benesic et al. Clinical Gastroenterology and Hepatology
- Expression of microRNA-155 in inflammatory cells modulates liver injury
- (2018) Delia Blaya et al. HEPATOLOGY
- Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort
- (2018) Rachel J. Church et al. HEPATOLOGY
- Pharmacogenomics of drug-induced liver injury (DILI): Molecular biology to clinical applications
- (2018) Kalaiyarasi Kaliyaperumal et al. JOURNAL OF HEPATOLOGY
- Extracellular vesicles: Novel mediator for cell to cell communications in liver pathogenesis
- (2018) Pradip B. Devhare et al. MOLECULAR ASPECTS OF MEDICINE
- The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients
- (2018) Bahtiyar Yilmaz et al. PLoS One
- A switch-variant model integrates the functions of an autoimmune variant of the phosphatase PTPN22
- (2018) Torkel Vang et al. Science Signaling
- Hepatic Damage by Natural Remedies
- (2018) Inmaculada Medina-Caliz et al. SEMINARS IN LIVER DISEASE
- Cell-based assay using glutathione-depleted HepaRG and HepG2 human liver cells for predicting drug-induced liver injury
- (2018) Jieyu Xu et al. TOXICOLOGY IN VITRO
- Effect of UGT2B7*2 and CYP2C8*4 polymorphisms on diclofenac metabolism
- (2018) Katarzyna E. Lazarska et al. TOXICOLOGY LETTERS
- Dissecting the molecular pathophysiology of drug-induced liver injury
- (2018) Hui Ye et al. WORLD JOURNAL OF GASTROENTEROLOGY
- A switch-variant model integrates the functions of an autoimmune variant of the phosphatase PTPN22
- (2018) Torkel Vang et al. Science Signaling
- Mitochondrial Damage-Associated Molecular Patterns: From Inflammatory Signaling to Human Diseases
- (2018) Serge Grazioli et al. Frontiers in Immunology
- Glutathione peroxidase 1 Pro198Leu variant contributes to the metabolic syndrome in men in a large Japanese cohort
- (2018) Masafumi Kuzuya et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- The association between the NAT2 genetic polymorphisms and risk of DILI during anti-TB treatment: a systematic review and meta-analysis
- (2018) Min Zhang et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Drug-induced liver injury: a safety review
- (2018) Miren García-Cortés et al. Expert Opinion On Drug Safety
- Biomarkers of drug-induced liver injury: progress and utility in research, medicine, and regulation
- (2018) Mitchell R. McGill et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Identification of Specific MicroRNA Biomarkers in Early Stages of Hepatocellular Injury, Cholestasis, and Steatosis in Rats
- (2018) Takumi Kagawa et al. TOXICOLOGICAL SCIENCES
- The Role of Tiopronin for the Prevention of Chemotherapy-Related Liver Toxicity in Advanced Colorectal Cancer Patients Treated with mFOLFOX7: A Prospective Analysis
- (2018) Xiao-peng Li et al. TUMORI
- The protein tyrosine phosphatase PTPN22 negatively regulates presentation of immune complex derived antigens
- (2018) Fiona Clarke et al. Scientific Reports
- Pharmacogenetic association between NAT2 gene polymorphisms and isoniazid induced hepatotoxicity: trial sequence meta-analysis as evidence
- (2018) Saif Khan et al. BIOSCIENCE REPORTS
- Drug-induced liver injury with skin reactions: Drugs and host risk factors, clinical phenotypes and prognosis
- (2018) Harshad Devarbhavi et al. LIVER INTERNATIONAL
- Extracellular vesicles in liver disease and beyond
- (2018) Laura Morán et al. WORLD JOURNAL OF GASTROENTEROLOGY
- MiR-122 and other microRNAs as potential circulating biomarkers of drug-induced liver injury
- (2017) Lawrence S. Howell et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study
- (2017) Paola Nicoletti et al. GASTROENTEROLOGY
- Drug-induced liver injury: recent advances in diagnosis and risk assessment
- (2017) Gerd A Kullak-Ublick et al. GUT
- Comparison of efficacy of folic acid and silymarin in the management of antiepileptic drug induced liver injury: a randomized clinical trial
- (2017) Masoumeh Asgarshirazi et al. Hepatobiliary & Pancreatic Diseases International
- Association of CYP2B6 gene polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese population
- (2017) Yu Wang et al. INFECTION GENETICS AND EVOLUTION
- Hepatotoxicity of Herbal Supplements Mediated by Modulation of Cytochrome P450
- (2017) Christopher Brewer et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis
- (2017) Andrea Iorga et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study
- (2017) Kevin Wing et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗ 35:02 as a risk factor
- (2017) Thomas Jacob Urban et al. JOURNAL OF HEPATOLOGY
- miR-122 Release in Exosomes Precedes Overt Tolvaptan-Induced Necrosis in a Primary Human Hepatocyte Micropatterned Coculture Model
- (2017) Merrie Mosedale et al. TOXICOLOGICAL SCIENCES
- Editor’s Highlight: An Impaired Immune Tolerance Animal Model Distinguishes the Potential of Troglitazone/Pioglitazone and Tolcapone/Entacapone to Cause IDILI
- (2017) Alastair Mak et al. TOXICOLOGICAL SCIENCES
- Editor’s Highlight: Nlrp3 Is Required for Inflammatory Changes and Nigral Cell Loss Resulting From Chronic Intragastric Rotenone Exposure in Mice
- (2017) Eileen M. Martinez et al. TOXICOLOGICAL SCIENCES
- A Multicenter and Randomized Controlled Trial of Bicyclol in the Treatment of Statin-Induced Liver Injury
- (2017) Wu Naiqiong et al. MEDICAL SCIENCE MONITOR
- New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease
- (2017) Mireia López-Riera et al. Frontiers in Pharmacology
- HLA-B*57 Allele Is Associated with Concomitant Anti-tuberculosis and Antiretroviral Drugs Induced Liver Toxicity in Ethiopians
- (2017) Zelalem Petros et al. Frontiers in Pharmacology
- Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients
- (2017) Sze Ling Chan et al. PLoS One
- Outcomes in Adults With Acute Liver Failure Between 1998 and 2013
- (2016) Adrian Reuben et al. ANNALS OF INTERNAL MEDICINE
- Activation of the Nrf2 signaling pathway in usnic acid-induced toxicity in HepG2 cells
- (2016) Si Chen et al. ARCHIVES OF TOXICOLOGY
- Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: Results from 152 marketed drugs with known liver injury profiles
- (2016) Jie Zhang et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury
- (2016) Francisco Javier Cubero et al. GASTROENTEROLOGY
- Preventive use of a hepatoprotectant against anti-tuberculosis drug-induced liver injury: A randomized controlled trial
- (2016) Simin Zhang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Idiosyncratic Drug-Induced Liver Injury: Is Drug-Cytokine Interaction the Linchpin?
- (2016) Robert A. Roth et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Profiles of miRNAs in serum in severe acute drug induced liver injury and their prognostic significance
- (2016) Mark W. Russo et al. LIVER INTERNATIONAL
- HLA-DRB1*16
- (2016) Paola Nicoletti et al. Pharmacogenetics and Genomics
- A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury
- (2015) Chote Luangchosiri et al. BMC Complementary and Alternative Medicine
- HLA-B*57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer
- (2015) C.-F. Xu et al. CLINICAL CANCER RESEARCH
- Plasma osteopontin in acute liver failure
- (2015) Praveen Srungaram et al. CYTOKINE
- Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study
- (2015) Naga Chalasani et al. GASTROENTEROLOGY
- Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports
- (2015) Einar S. Björnsson et al. HEPATOLOGY
- Drug-induced liver injury associated with stevens-Johnson syndrome/toxic epidermal necrolysis: Patient characteristics, causes, and outcome in 36 cases
- (2015) Harshad Devarbhavi et al. HEPATOLOGY
- The chemical, genetic and immunological basis of idiosyncratic drug–induced liver injury
- (2015) A Tailor et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Role of bicyclol in preventing drug-induced liver injury in tuberculosis patients with liver disease
- (2015) N-H. Chu et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Acute liver failure following atorvastatin dose escalation: Is there a threshold dose for idiosyncratic hepatotoxicity?
- (2015) Miguel F. Carrascosa et al. JOURNAL OF HEPATOLOGY
- miR-122 – A key factor and therapeutic target in liver disease
- (2015) Simonetta Bandiera et al. JOURNAL OF HEPATOLOGY
- Drug-induced liver injury: Interactions between drug properties and host factors
- (2015) Minjun Chen et al. JOURNAL OF HEPATOLOGY
- Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice
- (2015) Guruprasad P. Aithal LIVER INTERNATIONAL
- Enhanced Production of Adenosine Triphosphate by Pharmacological Activation of Adenosine Monophosphate-Activated Protein Kinase Ameliorates Acetaminophen-Induced Liver Injury
- (2015) MOLECULES AND CELLS
- Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01
- (2015) L R Parham et al. PHARMACOGENOMICS JOURNAL
- Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes
- (2015) Brenton R. Ware et al. TOXICOLOGICAL SCIENCES
- Calcium Contributes to the Cytotoxic Interaction Between Diclofenac and Cytokines
- (2015) Ashley R. Maiuri et al. TOXICOLOGICAL SCIENCES
- Lysosomal Cholesterol Accumulation Sensitizes To Acetaminophen Hepatotoxicity by Impairing Mitophagy
- (2015) Anna Baulies et al. Scientific Reports
- Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease
- (2015) Liane Rabinowich et al. Biomed Research International
- Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps
- (2015) Rolf Teschke et al. Frontiers in Pharmacology
- Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotype
- (2015) Yuji Miura et al. BMC CANCER
- High-content screening of drug-induced mitochondrial impairment in hepatic cells: effects of statins
- (2014) Laia Tolosa et al. ARCHIVES OF TOXICOLOGY
- Mechanisms of drug-induced liver injury
- (2014) Camilla Stephens et al. Current Opinion in Allergy and Clinical Immunology
- Alterations of Canalicular ATP-Binding Cassette Transporter Expression in Drug-Induced Liver Injury
- (2014) Gernot Zollner et al. DIGESTION
- Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury
- (2014) Mercedes Robles–Diaz et al. GASTROENTEROLOGY
- Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1
- (2014) Ynto S. de Boer et al. GASTROENTEROLOGY
- Widespread context dependency of microRNA-mediated regulation
- (2014) F. Erhard et al. GENOME RESEARCH
- Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome
- (2014) Mitchell R. McGill et al. HEPATOLOGY
- Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump
- (2014) Michael D. Aleo et al. HEPATOLOGY
- Prospective Validation ofHLA-DRB1*07:01Allele Carriage As a Predictive Risk Factor for Lapatinib-Induced Liver Injury
- (2014) Daniel J. Schaid et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of bicyclol in preventing chemotherapeutic agent-induced liver injury in patients over 60 years of age with cancer
- (2014) Xiaoyuan Li et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Age-related differences in reporting of drug-associated liver injury: Data-mining of WHO Safety Report Database
- (2014) Christine M. Hunt et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Drug-Induced Liver Injury with Autoimmune Features
- (2014) David Foureau et al. SEMINARS IN LIVER DISEASE
- Genetic Basis of Drug-Induced Liver Injury: Present and Future
- (2014) Thomas Urban et al. SEMINARS IN LIVER DISEASE
- Hepatotoxicity Induced by Herbal and Dietary Supplements
- (2014) M. Lucena et al. SEMINARS IN LIVER DISEASE
- Glutathione and mitochondria
- (2014) Vicent Ribas et al. Frontiers in Pharmacology
- AOPPs and the progression of kidney disease
- (2014) Wei Cao et al. Kidney International Supplements
- Mechanisms of Drug-induced Liver Injury
- (2013) Liyun Yuan et al. Clinics in Liver Disease
- Isoniazid-induced cell death is precipitated by underlying mitochondrial complex I dysfunction in mouse hepatocytes
- (2013) Kang Kwang Lee et al. FREE RADICAL BIOLOGY AND MEDICINE
- Incidence, Presentation, and Outcomes in Patients With Drug-Induced Liver Injury in the General Population of Iceland
- (2013) Einar S. Björnsson et al. GASTROENTEROLOGY
- Associations Between HLA-DRB1*0102, HLA-B*5801, and Hepatotoxicity During Initiation of Nevirapine-Containing Regimens in South Africa
- (2013) Elizabeth Phillips et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Extracellular vesicles: Exosomes, microvesicles, and friends
- (2013) Graça Raposo et al. JOURNAL OF CELL BIOLOGY
- Carnitine for prevention of antituberculosis drug-induced hepatotoxicity: A randomized, clinical trial
- (2013) Shima Hatamkhani et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- CHOP is a critical regulator of acetaminophen-induced hepatotoxicity
- (2013) Dotan Uzi et al. JOURNAL OF HEPATOLOGY
- Lessons from look-back in acute liver failure? A single centre experience of 3300 patients
- (2013) William Bernal et al. JOURNAL OF HEPATOLOGY
- HLA Haplotype Determines Hapten or p-i T Cell Reactivity to Flucloxacillin
- (2013) N. Wuillemin et al. JOURNAL OF IMMUNOLOGY
- Role of chemical structures and the 1331T>C bile salt export pump polymorphism in idiosyncratic drug-induced liver injury
- (2013) Eugenia Ulzurrun et al. LIVER INTERNATIONAL
- HLA Alleles Influence the Clinical Signature of Amoxicillin-Clavulanate Hepatotoxicity
- (2013) Camilla Stephens et al. PLoS One
- Differential Stability of Cell-Free Circulating microRNAs: Implications for Their Utilization as Biomarkers
- (2013) Verena Köberle et al. PLoS One
- Evaluation of the use of imaging parameters for the detection of compound-induced hepatotoxicity in 384-well cultures of HepG2 cells and cryopreserved primary human hepatocytes
- (2013) Helen Garside et al. TOXICOLOGY IN VITRO
- Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria
- (2013) Derick Han et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Preclinical Strategy to Reduce Clinical Hepatotoxicity Using in Vitro Bioactivation Data for >200 Compounds
- (2012) Melanie Z. Sakatis et al. CHEMICAL RESEARCH IN TOXICOLOGY
- The Effects of Heparins on the Liver: Application of Mechanistic Serum Biomarkers in a Randomized Study in Healthy Volunteers
- (2012) A H Harrill et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: Lessons learned from acetaminophen hepatotoxicity
- (2012) Hartmut Jaeschke et al. DRUG METABOLISM REVIEWS
- Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure
- (2012) Pedro E. Marques et al. HEPATOLOGY
- Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury
- (2012) Manal M. Monshi et al. HEPATOLOGY
- High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury
- (2012) Minjun Chen et al. HEPATOLOGY
- Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome
- (2012) Chun-Yu Wei et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation
- (2012) Mitchell R. McGill et al. JOURNAL OF CLINICAL INVESTIGATION
- IRE1α activation protects mice against acetaminophen-induced hepatotoxicity
- (2012) Kyu Yeon Hur et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Human monocyte-derived cells with individual hepatocyte characteristics: a novel tool for personalized in vitro studies
- (2012) Andreas Benesic et al. LABORATORY INVESTIGATION
- Pharmacogenetic Study of Drug-Metabolising Enzyme Polymorphisms on the Risk of Anti-Tuberculosis Drug-Induced Liver Injury: A Meta-Analysis
- (2012) Yu Cai et al. PLoS One
- Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire
- (2012) D. A. Ostrov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms of Hepatocellular Toxicity Associated with Dronedarone—A Comparison to Amiodarone
- (2012) Andrea Felser et al. TOXICOLOGICAL SCIENCES
- MiR-122 in hepatic function and liver diseases
- (2012) Jun Hu et al. Protein & Cell
- The danger theory: 20 years later
- (2012) Thomas Pradeu et al. Frontiers in Immunology
- Genetic variations in drug-induced liver injury (DILI): resolving the puzzle
- (2012) Camilla Stephens et al. Frontiers in Genetics
- Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent
- (2011) Jing Yuan et al. AIDS
- Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States
- (2011) Antonia F. Stepan et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Case Definition and Phenotype Standardization in Drug-Induced Liver Injury
- (2011) G P Aithal et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II Alleles
- (2011) M. Isabel Lucena et al. GASTROENTEROLOGY
- Drug-Induced liver injury with hypersensitivity features has a better outcome: A single-center experience of 39 children and adolescents
- (2011) Harshad Devarbhavi et al. HEPATOLOGY
- Circulating microRNAs as potential markers of human drug-induced liver injury
- (2011) Philip J. Starkey Lewis et al. HEPATOLOGY
- HLA-DQA1*02:01 Is a Major Risk Factor for Lapatinib-Induced Hepatotoxicity in Women With Advanced Breast Cancer
- (2011) Colin F. Spraggs et al. JOURNAL OF CLINICAL ONCOLOGY
- Causality assessment methods in drug induced liver injury: Strengths and weaknesses
- (2011) Miren García-Cortés et al. JOURNAL OF HEPATOLOGY
- Recurrent Drug-Induced Liver Injury (DILI) with different drugs in the Spanish Registry: The dilemma of the relationship to autoimmune hepatitis
- (2011) M.I. Lucena et al. JOURNAL OF HEPATOLOGY
- Hepatotoxicity related to antirheumatic drugs
- (2011) Guruprasad P. Aithal Nature Reviews Rheumatology
- High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study
- (2011) G Yimer et al. PHARMACOGENOMICS JOURNAL
- Pharmacogenetic & Pharmacokinetic Biomarker for Efavirenz Based ARV and Rifampicin Based Anti-TB Drug Induced Liver Injury in TB-HIV Infected Patients
- (2011) Getnet Yimer et al. PLoS One
- Delayed drug hypersensitivity: models of T-cell stimulation
- (2010) Jacqueline Adam et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Enhanced Susceptibility of HLA-mediated Ticlopidine-induced Idiosyncratic Hepatotoxicity by CYP2B6 Polymorphism in Japanese
- (2010) Noritaka Ariyoshi et al. Drug Metabolism and Pharmacokinetics
- Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity
- (2010) Shadi Baniasadi et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injury
- (2010) M. Isabel Lucena et al. HEPATOLOGY
- Polymerase γ Gene POLG determines the risk of sodium valproate-induced liver toxicity
- (2010) Joanna D. Stewart et al. HEPATOLOGY
- Drug-induced autoimmune hepatitis: Clinical characteristics and prognosis
- (2010) Einar Björnsson et al. HEPATOLOGY
- Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury
- (2010) Peter T. Donaldson et al. JOURNAL OF HEPATOLOGY
- A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury
- (2010) Jonathan B Singer et al. NATURE GENETICS
- Drug-induced liver injury: past, present and future
- (2010) Ann K Daly PHARMACOGENOMICS
- Idiosyncratic Drug-Induced Liver Injury and the Role of Inflammatory Stress with an Emphasis on an Animal Model of Trovafloxacin Hepatotoxicity
- (2010) Patrick J. Shaw et al. TOXICOLOGICAL SCIENCES
- Interference with Bile Salt Export Pump Function Is a Susceptibility Factor for Human Liver Injury in Drug Development
- (2010) Ryan E. Morgan et al. TOXICOLOGICAL SCIENCES
- A systems biology approach to understanding elevated serum alanine transaminase levels in a clinical trial with ximelagatran
- (2009) Ulf Andersson et al. BIOMARKERS
- Role of the bile salt export pump, BSEP, in acquired forms of cholestasis
- (2009) Bruno Stieger DRUG METABOLISM REVIEWS
- Intravenous N-Acetylcysteine Improves Transplant-Free Survival in Early Stage Non-Acetaminophen Acute Liver Failure
- (2009) William M. Lee et al. GASTROENTEROLOGY
- Phenotypic characterization of idiosyncratic drug-induced liver injury: The influence of age and sex
- (2009) M. Isabel Lucena et al. HEPATOLOGY
- Intrinsic versus Idiosyncratic Drug-Induced Hepatotoxicity--Two Villains or One?
- (2009) R. A. Roth et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
- (2009) Ann K Daly et al. NATURE GENETICS
- Drug-induced liver injury: insights from genetic studies
- (2009) Raúl J Andrade et al. PHARMACOGENOMICS
- Inflammatory Stress and Idiosyncratic Hepatotoxicity: Hints from Animal Models
- (2009) X. Deng et al. PHARMACOLOGICAL REVIEWS
- Epidemiology of Idiosyncratic Drug-Induced Liver Injury
- (2009) Lauren Bell et al. SEMINARS IN LIVER DISEASE
- High-Mobility Group Box-1 Protein and Keratin-18, Circulating Serum Proteins Informative of Acetaminophen-Induced Necrosis and Apoptosis In Vivo
- (2009) Daniel J. Antoine et al. TOXICOLOGICAL SCIENCES
- BGP-15 inhibits caspase-independent programmed cell death in acetaminophen-induced liver injury
- (2009) Gábor Nagy et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The role of osteopontin in inflammatory processes
- (2009) Susan Amanda Lund et al. Journal of Cell Communication and Signaling
- Physiochemical drug properties associated with in vivo toxicological outcomes
- (2008) Jason D. Hughes et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Endocytosis mechanisms and the cell biology of antigen presentation
- (2008) Sven Burgdorf et al. CURRENT OPINION IN IMMUNOLOGY
- Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil
- (2008) L. G. Possuelo et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- GlutathioneS-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury
- (2008) M. Isabel Lucena et al. HEPATOLOGY
- Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: Search for signals
- (2008) Craig Lammert et al. HEPATOLOGY
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
- In Vitro Assessment of Mitochondrial Dysfunction and Cytotoxicity of Nefazodone, Trazodone, and Buspirone
- (2008) James A. Dykens et al. TOXICOLOGICAL SCIENCES
- Cellular Imaging Predictions of Clinical Drug-Induced Liver Injury
- (2008) Jinghai J. Xu et al. TOXICOLOGICAL SCIENCES
- Gene expression profiles of murine fatty liver induced by the administration of methotrexate
- (2008) Min-Ho Lee et al. TOXICOLOGY
- The p-i Concept
- (2008) Werner J. Pichler World Allergy Organization Journal
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started